Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable in the population. This consensus statement by HEART UK is based on the evidence that Lp(a) is an independent cardiovascular disease (...
Civeira, F. et al. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation.Arterioscler. Thromb. Vasc. Biol.25, 1960–1965 (2005). ArticleCASPubMedGoogle Scholar Oosterveer, D. M., Versmissen, J....
Canadian Consensus Conference on Cholesterol: final report. The Canadian Consensus Conference on the Prevention of Heart and Vascular Disease by Altering Serum Cholesterol and Lipoprotein Risk Factors. 关键词: Humans Coronary Disease Arteriosclerosis Cholesterol Lipoproteins Adolescent Adult Child Canada Risk ...
Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe he...
on replacement of 5% of energy as carbohydrates with specific fatty acids under isocaloric conditions, assuming baseline high-density lipoprotein cholesterol (HDL-C) levels of 50 mg/dL (1.30 mmol/L), low-density lipoprotein cholesterol (LDL-C) levels of 130 mg/dL (3.37 mmol/L), and ...
In this group of patients a high level of high-density lipoprotein (HDL) cholesterol was associated with lower risk of HF, but there was no association with low-density lipoprotein (LDL) cholesterol. Bertoni et al. also reported a link be- tween idiopathic cardiomyo...
Consensus Conference. Lowering blood cholesterol to prevent heart disease.JAMA1985;253:2080–2086. Google Scholar Pritikin N. Optimal dietary recommendations: a public health responsibility.Prev Med1982;11:733–739. CASGoogle Scholar Blackburn H. Diet and atherosclerosis: epidemiologic evidence and public...
(0 to 3 points), serum creatinine (0 to 5 points), high density lipoprotein cholesterol (HDL-c, 0 to 2 points), QRS width on ECG (0 or 3 points) and history of myocardial infarction (0 or 3 points) or CABG (0 or 2 points), all of which were measured or obtained at hospital ...
Seferović PM, Paulus WJ, Rosano G, et al (2024) Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail (1879–0844 (Electronic)):22(21):45. ...
Currently, there are several lipid lowering agents, and the most commonly used are statins. Statins are well known for their effects in reducing LDL cholesterol; however, they do not have any effects on lipoprotein a [Lp(a)]. Lp(a), which is encoded by theLPAgene is a pro-atherogenic ...